Matthew Strobeck insider trades

Open-market stock purchases and sales by Matthew Strobeck, Director at QuidelOrtho Corp, from SEC Form 4 filings since Mar 12, 2009.

Track record: 25% of 8 scored buys are up 5% or more since purchase, averaging +8%.

Recent trades

DateStockTradeValue
May 29, 2026QDEL QuidelOrtho CorpBought (not open market)—
May 29, 2026QDEL QuidelOrtho CorpBought (not open market)—
Feb 13, 2026QDEL QuidelOrtho CorpBought$240K
Jan 2, 2026BDSX Biodesix IncBought (not open market)—
Jan 2, 2026BDSX Biodesix IncBought (not open market)—

Companies traded

  • QDEL QuidelOrtho Corp: 5 buys, last May 29, 2026
  • BDSX Biodesix Inc: 9 buys, last Jan 2, 2026
  • AXDX Accelerate Diagnostics, Inc: 8 buys, last Jan 23, 2024
  • MBLX Metabolix, Inc: 16 buys, last Jan 27, 2016
  • SNTS Santarus Inc: other filings, last May 15, 2012

Get free alerts when Matthew Strobeck files a new trade →